3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Leukemia
42
Leukemia, Lymphocytic, Chronic, B-Cell
41
Lymphoma
30
Myelodysplastic Syndromes
24
Precursor Cell Lymphoblastic Leukemia-Lymphoma
19
Lymphoma, Non-Hodgkin
18
Hodgkin Disease
18
Leukemia, Myeloid, Acute
17
Multiple Myeloma
16
Myeloproliferative Disorders
14
Lymphoma, Mantle-Cell
10
Lymphoma, Follicular
10
Neoplasms, Plasma Cell
9
Lymphoma, Large B-Cell, Diffuse
9
Lymphoma, B-Cell, Marginal Zone
9
Leukemia, Myeloid, Chronic-Phase
9
Congenital Abnormalities
9
Lymphoma, T-Cell, Peripheral
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
8
Hematologic Neoplasms
8
Burkitt Lymphoma
8
Anemia, Aplastic
8
Waldenstrom Macroglobulinemia
7
Recurrence
7
Myelodysplastic-Myeloproliferative Diseases
7
Lymphoma, Large-Cell, Immunoblastic
7
Primary Myelofibrosis
6
Leukemia, Myelomonocytic, Chronic
6
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
6
Leukemia, Myeloid, Accelerated Phase
6
Interventions
Nivolumab
13
Ipilimumab
10
pembrolizumab
8
cemiplimab
6
Surveys and Questionnaires
6
Biopsy
6
aldesleukin
5
Radiotherapy
5
Interleukin-2
5
Blood Specimen Collection
5
Temozolomide
4
Sirolimus
4
Photochemotherapy
4
Mohs Surgery
4
HhAntag691
4
Fluorouracil
4
Educational Status
4
Cyclophosphamide
4
sonidegib
3
fludarabine phosphate
3
fludarabine
3
avelumab
3
Vemurafenib
3
Surgical Procedures, Operative
3
Radiation
3
Petrolatum
3
Cetuximab
3
Aminolevulinic Acid
3
trametinib
2
dabrafenib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Skin Neoplasms
×
Alemtuzumab
×
Clear all
NCT06705608
2024-11-26
MS; FTY720
University of British Columbia
Completed
4,000 enrolled